Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LakeShore Biopharma Co's Average Total Inventories for the quarter that ended in Mar. 2025 was $29.73 Mil. LakeShore Biopharma Co's Revenue for the
six
months ended in Mar. 2025 was $33.52 Mil.
LakeShore Biopharma Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.89.
LakeShore Biopharma Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025
increased
from Sep. 2024 (0.54) to Sep. 2024 (0.89)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
LakeShore Biopharma Co's Days Inventory for the
six
months ended in Mar. 2025 was 912.76.
Inventory Turnover measures how fast the company turns over its inventory within a year.
LakeShore Biopharma Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.20.
LakeShore Biopharma Co (OTCPK:LSBCF) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
LakeShore Biopharma Co's Days Inventory for the
six
months ended in Mar. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LakeShore Biopharma Co Inventory-to-Revenue Related Terms
LakeShore Biopharma Co Inventory-to-Revenue Historical Data
* Premium members only.
The historical data trend for LakeShore Biopharma Co's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSBCF vs ACUT, PPCB, ENSC: Inventory-to-Revenue Comparison
For the Biotechnology subindustry, LakeShore Biopharma Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LakeShore Biopharma Co Inventory-to-Revenue vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where LakeShore Biopharma Co's Inventory-to-Revenue falls into.
LakeShore Biopharma Co Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LakeShore Biopharma Co's Inventory-to-Revenue for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LakeShore Biopharma Co (LSBCF) has a Inventory-to-Revenue of 0.89 as of Mar. 2025. Inventory-to-Sales ratio is the total inventories divided by total sales. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Inventory-to-Revenue too high?
LakeShore Biopharma Co's current Inventory-to-Revenue is 0.89.
How does LakeShore Biopharma Co's Inventory-to-Revenue compare to ACUT and PPCB?
LakeShore Biopharma Co's Inventory-to-Revenue of 0.89 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory-to-Revenue for a Biotechnology company?
A good Inventory-to-Revenue depends on the Biotechnology industry context. However, Inventory-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory-to-Revenue mean?
A high Inventory-to-Revenue can signal that a stock is expensive relative to its fundamentals. Inventory-to-Sales ratio is the total inventories divided by total sales. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Inventory-to-Revenue is 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Inventory-to-Revenue of 0.89. The current Inventory-to-Revenue is 0.89. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory-to-Revenue calculated?
Inventory-to-Revenue is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Inventory-to-Revenue is 0.89 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSBCF has been successfully added to your 
